Brief History

  • After 2008
  • 2007~1997
  • 1996~1977
  • 1976~1958
  • 1957~1897
  • 2022
    Dong Wha Pharm-Oncocross to conduct AI-based joint research on new indications for an anticancer drug
    Dong Wha Pharm reveals a new TV-CF episode, “Don’t bear it, use EACH”
    Dong Wha Pharm – Cimplrx to collaborate for the development of AI-based immune disease treatment
    Dong Wha Pharm releases “EACH Gargle”
    Dong Wha Pharm’s 17th president Han Jonghyun appointed
    Dong Wha Pharm’s “Gas Whal Myung Su-Q” designated as Golden Brand
    Dong Wha Pharm releases the first brush-type athlete’s foot treatment, “Bargio Once”
    Dong Wha Pharm releases “SEVITAB Gel,” an acne treatment
    Dong Wha Pharm releases the 125th anniversary edition Whal Myung Su in collaboration with “Stanley”
    Dong Wha Pharm and Animuscure sign a joint research agreement to develop innovative sarcopenia treatmentdd
    Dong Wha Pharm Chairman Yoon Doh Joon publishes an essay, “Beautiful Namsan with Blue Eyebrow Peaks”
    Dong Wha Pharm releases the 125th anniversary package that reinterpreted the early day Whal Myung Su design that is reminiscent of its founding in 1897
    “Whal Myung Su 1897” pop-up store opened in commemoration of the 125th anniversary of Dong Wha Pharm and Whal Myung Su
    Dong Wha Pharm’s [National Healthy Life Campaign] ad won advertisement awards
    Dong Wha Pharm invests in a digital therapeutics development company, “HAII”
    Dong Wha Pharm and Pfizer Pharmaceuticals Korea renew a contract for the sale of Pristiq Extended-Release Tablet, an antidepressant
    2021
    Dong Wha Pharm releases a spray-type rhinitis remedy, “Comakiten Nasal Spray”
    Sales of Korea’s best-selling periodontal treatment, “EACH,” exceeds KRW 20 billion
    Dong Wha Pharm appoints Yoo Junha as the new president
    Dong Wha Pharm’s Symbiosis ad series wins the “Good Ad Award”
    Dong Wha Pharm makes an equity investment in Next Biomedical
    Whal Myung Su’s new campaign for 2021 – No. 1 [Best CF] by TVCF
    Dong Wha Pharm signs an exclusive domestic license agreement for a resistant hypertension treatment
    Dong Wha Pharm releases the only athlete’s foot treatment with 6 complex ingredients in Korea, “Bargio® Modu Cream”
    Dong Wha Pharm releases a new TV-CF campaign for a wound-healing medicine, “Fucidin”
    Dong Wha Pharm holds the 7th Summer Saeng-saek Exhibition
    Dong Wha Pharm introduces an extended-release nalbuphine analgesic injection in Korea
    Dong Wha Pharm releases “Sogaften Tab,” a gastrointestinal medicine with complex famotidine ingredient
    Dong Wha Pharm releases a functional cosmetic product, “Fucid Cream”
    Dong Wha Pharm holds a symposium to commemorate the release of “Intrinsic IB Gel MD”
    Dong Wha Pharm releases the 124th anniversary edition Whal Myung Su
    Dong Wha Pharm’s [Travel] ad wins the ad awards
    2020
    Dong Wha Pharm launches “Vi-La-Bael,” a type of vitamins for maintaining nutritional balance
    Dong Wha Pharm signs an MOU with JETEMA on the joint development of botulinum toxin treatment
    Dong Wha Pharm “Whal Myung Su” wins the Good Ad Award in the TV category
    Dong Wha Pharm releases “AlpsB4,” a fatigue remedy
    Dong Wha Pharm makes an equity investment in VUNO, an AI healthcare solution company
    Dong Wha Pharm acquires Medyssey, a spinal implant manufacturer
    Dong Wha Pharm launches a denture cleanser, “Say Clean”
    Dong Wha Pharm release an easy-to-carry “Whal Myung Su-U (遊)”
    Dong Wha Pharm releases the 123rd anniversary edition Whal Myung Su
    Dong Wha Pharm releases a liquid liver function enhancer, “Helmin Livers Solution”
    Dong Wha Pharm releases an energy drink, “Chunhajangsa Sang Sang Ton Up”
    Dong Wha Pharm’s [Symbiosis] ad wins the Korea Advertising Awards
    2019
    Dong Wha Pharm establishes the Entrepreneurship Fund for the cultivation of startup ecology
    Dong Wha Pharm launched a new TV-CF campaign for Pancold
    Dong Wha Pharm releases a sore throat treatment, Mogaften
    Dong Wha Pharm "Whal Myung" participates in the 2019 F/W New York Fashion Week as an official skincare partner
    Dong Wha Pharm donates the sales proceeds of the Whal Myung Su’s 121st anniversary edition
    Ki Hwan Park appointed as Dong Wha Pharm’s 16th president
    Dong Wha Pharm "Whal Myung Su" wins the People’s Choice Advertising Award
    Dong Wha Pharm "Whal Myung Su" wins the Ad of the Year Award
    The 4th Yoon Doh Joon Award for Research cites the late Professor Lim Sewon of the Department of Psychiatry at Kangbuk Samsung Hospital
    Dong Wha Pharm launches a new TV-CF campaign for Bu Chae Pyo Fucidin "Fu~ (hoo) with Mother's Care"
    Dong Wha Pharm wins the Minister of Food and Drug Safety Award at the 2019 Future Happiness Awards
    Dong Wha Phar-Sempio releases "Pear-Luffa Cheongdamwon," a health drink
    Dong Wha Pharm acquires ISO 37001, an anti-corruption management system certification
    Dong Wha Pharm "Whal Myung Su" launches the follow-up TV-CF of the "Good Digestion Today" campaign
    Dong Wha Pharm EACH reveals its new TV-CF, "Time to Start EACH"
    Dong Wha Pharm Skincare renaissance product, "Whal Myung," is exclusively available in Sephora
    Dong Wha Pharm names Professor Nam Gitaek of Severance Biomedical Science Institute, Yonsei University College of Medicine, as the grand prize winner of the Dong Wha Academic Award
    Dong Wha Pharm opens the "Whal Myung" flagship store in Samcheong-dong
    2018
    Dong Wha Pharm recruits Kim Daehyun, assigning him the director of its OTC Development/Marketing business
    Dong Wha Pharm launches "Donghee's Curious" healthy living campaign
    Dong Wha Pharm donates the proceeds of the sales of the Whal Myung Su 120th anniversary edition
    Yoo Gwangyeol appointed as Dong Wha Pharm's 15th president
    Dong Wha Pharm obtains "AA", the industry's top CP rating, from Korea Fair Trade Commission in 2017
    Dong Wha Pharm's WHALMYUNG Skin Elixir reported as sold out at overseas K-beauty pop-up stores
    Dong Wha Pharm's quinolone antibacterial agent, "Zabolante," wins at the 19th Korea New Drug Award (KNDA)
    The 2018 GHASONG Art Award competition
    Bu Chae Pyo GHASONG Foundation – KAMS named Han Mancheong as the winner of the KAMS Honor in Medicine Award, and Yoo Soyoung as the winner of the Yoon Gwang-yeol Award for Medicine
    Gas Whal Myung Su-Q maintains its No. 1 "Golden Brand" status for 14 consecutive years
    Dong Wha Pharm and Pfizer Korea extend their major CNS products contract
    Bu Chae Pyo GHASONG Foundation presents the 7th Yoon Gwang-yeol Dedicated Dental Service Award to "Taegu Dental Association"
    First-ever collaboration project between the pharmaceutical and fashion industries launched
    Dong Wha Pharm holds a declaration ceremony to enhance the "2018 Fair Trade Compliance Program (CP)"
    Dong Wha Pharm GPARK releases energy drink in collaboration with Bexel
    Dong Wha Pharm participating in the "2018 Jeong Dong Culture Night"
    Dong Wha Pharm releases "Whal Myung" basic skincare line
    Dong Wha Pharm's 3D animation, "Donghee's Curious" and Whal Myung Su "REBORN," became the No. 1 ad in the pharmaceutical industry at the YouTube Korea Popular Ads Video
    Dong Wha Pharm opens the "1897 Pharmacy" and "Rescue Emergency Center" experience booths at KidZania
    Dong Wha Pharm's cosmetic product, "Whal Myung," was well received at the China Beauty Expo 2018
    Bu Chae Pyo GHASONG Foundation and Dong Wha Pharm hold the 6th Summer Saeng-saek Exhibition
    Bu Chae Pyo GHASONG Foundation and Dong Wha Pharm hold the "2018 GHASONG Art Award" ceremony
    Bu Chae Pyo Whal Myung Su launches the TV-CF campaign that takes care of people’s hearts
    Dong Wha Pharm’s global skincare brand, "Whal Myung," now available at Lotte Duty Free
    Dong Wha Pharm releases two types of Pancold-I, a cold medicine for children
    2017
    Dong Wha Pharm's Bu Chae Pyo Fucidin reaches KRW20 billion in annual sales
    Dong Wha Pharm signs a licensing and supply contract with 12 MENA countries for Zabolante, a quinolone antibacterial compound and the 23rd new drug developed in Korea
    Dong Wha Pharm signs a contract for the exclusive sale of Genzyme Korea's Seprafilm®, an FDA-approved, anti-adhesion agent
    Dong Wha Pharm signs a contract with Ajou University's Industry-Academia Collaboration Foundation for the "patient-friendly, oral disintegrating tab medicine technology transfer"
    Gas Whal Myung Su-Q is ranked first at K-BPI for 13 consecutive years
    Dong Wha Pharm signs a license and supply (sale) contract in China for Korea's 23rd new quinolone antibacterial compound, Zabolante
    Bu Chae Pyo Fucidin wins the Gold Award for "Ad of the Year" from the Korea Advertising Society
    Bu Chae Pyo Fucidin wins the Minister of Health and Welfare Award in the "Safe & Healthy Children Happy Awards" event
    Dong Wha Pharm – Kangstem Biotech establishes joint venture DNK Corporation Ltd.
    Dong Wha Pharm signs an export contract for the energy drink GPARK to Cambodia
    Dong Wha Pharm's toothpaste-type gum treatment "EACH" chosen as "2017 Brand of the Year"
    Dong Wha Pharm and GSK Consumer Healthcare sign a general-medicine sale and supply agreement (OTC field)
    Dong Wha Pharm's moisturizer exclusive for clinics and hospitals chosen as [2017 Consumer Power Hit Award] winner in the Moisturizer category
    "Dong Wha Lecture Series," the cradle of Dong Wha Pharm's knowledge management, exceeds 100-time delivery
    Dong Wha Pham and MSD Korea sign a license agreement contract for the antidepressant Remeron Tab & SolTAb
    Dong Wha Pharm and Kangstem Biotech's joint venture (DNK Corporation) releases its first cosmetic product, BENESTEM Human CBCM Cream
    Dong Wha Pharm Bu Chae Pyo Fucidin launches a healing TV-CF campaign that embraces even the wounded heart
    Yoon Doh Joon, the president of Dong Wha Pharm, is named recipient of the 53rd Dong Am Pharmaceutical Award
    Dong Wha Pharm wins the 2017 Employee Ownership Minister of Employment and Labor Award
    Dong Wha Pharm's company magazine 1897 Times wins the 2017 Korea Business Communication Award's New York Festival Award
    Dong Wha Pharm successfully completes Dermatology Symposium
    Dong Wha Pharm launches the "Indigestion-free and Healthy Travel" campaign with Korail Seoul Office
    Dong Wha Pharm's toothpaste-type gum treatment EACH maintaining its fast growth
    2016
    Bu Chae Pyo Fucidin wins the Seoul Creative Festival's main award
    Dong Wha Pharm appoints Sohn Ji-hoon as its new CEO
    Dong Wha Pharm and Kangstem Biotech sign an MOU for stem cell culture commercialization
    Gas Whal Myung Su-Q maintains its top ranking in K-BPI for 12 consecutive years
    Dong Wha Pharm releases a new, pocket-type Fucidin ointment
    Dong Wha Pharm signs an export contract with Mongolia for Mi In Whal Myung Su
    Dong Wha Pharm signs an agreement with the Korea Drug Development Fund for a natural asthma treatment candidate
    Dong Wha Pharm releases "Floradin," a new antihistamine in liquid form
    Bu Chae Pyo GHASONG Foundation and Dong Wha Pharm hold the 5th "Summer Saeng-saek Exhibition"
    Dong Wha Pharm's cold preparation, Pancold-S, obtains US FDA and DEA export approvals
    The Bu Chae Pyo GHASONG Foundation and Dong Wha Pharm hold the 2016 GHASONG Art Award ceremony
    Dong Wha Pharm and UNIST sign an R&D cooperation MOU to treat Alzheimer's disease
    Dong Wha Pharm releases Kkoma Whal Myung Su, a digestive syrup for children
    2015
    Annual Sales of Gum Treatment "EACH" Tops KRW1 Billion
    Quinolone Antibacterial Agent Zabolante Certified as a NET
    Whal Myung Su Q (sparkling) Named "No.1 Brand Power"for 11 Consecutive Years
    Dong Wha Obtains Approval for Zabolante from MFDS
    Dong Wha–Ajou University Medical Center sign an MOU for Joint Research and Business Cooperation
    Mi In Whal Myung Su for women released
    2014
    Dong Wha Launches 'Clzapine' for Treatment of Refractory Schizophrenia
    Whal Myung Su-UNICEF Co-host 2nd 'Life-Saving Water' Campaign
    Won Golden Brand (Selected No.1 Brand in K-BPI for Tenth Consecutive Year, Whal Myung Su Q (sparkling))
    Launched Clinic and Hospital Cosmetic Brand 'LEDA'
    Won Customer Satisfaction Category Top Winner of Health Industry Awards(Each)
    Formed Partnership with Kyung Hee University for Technology Transfer and Business-Academia Collaboration
    Hosted 4th 'Summer Saeng-saek Jeon'
    Hosted Award Ceremony for 2014 GHASONG Art Award
    Dong Wha and Boryung Co-hosted 'Fimasartan Family Symposium'
    Corporated Newsletter '1897 Times' Wins KCMA Chairman's Award at 2014 Korea Communication Awards
    Launched Dental Care Brand 'Good Habit'
    2013
    Fucidin Named 'Best Brand for Young Children' for Second Consecutive Year
    Whal Myung Su-UNICEF Co-host 'Life-Saving Water' Campaign
    Dong Wha Forms Strategic Partnership with Laboratorios Cinfa
    Dong Wha Pharmaceuticals Named Winner in Best Brand Category for Oh Song Innovative Medicine Award Third 'Summer Saeng-Saek' Exhibition Takes Place
    '2013 Gha Song Art Award' Takes Place
    Dong Wha Launches Antihypertensive Drug 'LaCor Tablet'
    Dong Wha Launches Scalp and Hair Care Brand 'Never Say Good' Shampoo and Tonic
    Dong Wha Forms Partnership with Dongguk University for Natural Substance Allergic Rhinitis Drug
    1897 Times Named Best New Corporate Newsletter at Korea Communication Award 2013
    Dong Wha Wins U.S. Patent for Herbal Treatment for Diabetic Nephropathy
    2012
    Fucidin Named 'Best Brand for Young Children'
    Dong Wha Launches Dye-free Caffeine-free Liquid type Analgesic 'Trisfen'
    Je Hwa Park Inaugurated as Vice Chairman of Dong Wha Pharmaceuticals
    Dong Wha Launches New-concept Plaster 'MiniOn Plaster'
    First Gha Song Art Award Ceremony takes place
    Dong Wha-Bu Chae Pyo Gha Song Foundation Co-host '2nd Summer Saeng-saek' Exhibition
    Dong Wha named Innovative Pharmaceutical Company
    Dong Wha Wins Second Consecutive Oh Song Innovative Medicine Award
    Dong Wha Launches PANCOLD-VITA, PANCOLD-VITA Tablet
    Dong Wha Pharm forms strategic partnership with Henkel Home Care Korea
    Moisturizer Brand Danke Launches INTRINSIC
    Dong Wha-Boryung Pharm Tie Up for Co-development and Co-marketing of Diuretic Combination Drug 'Kanarb'
    2011
    Launched preservative free Whal Myung Su Q (sparkling)
    Formed exclusive contract with Novartis (entire OTC line)
    Signed an agreement for Biz-love Farm-love ( with Jeoge village, Chungju, Chungcheongbuk-do)
    Launched 'EACH paste'
    DW1029M (treatment for nephritis) obtains a patent in Canada
    Declaration of the 'Vision 120'
    Chairman Doh-Joon Yoon gave a lecture to CEOs of long-lived companies at a lecture hosted by Business School, Seoul National University (topic: Exploring DNA of long-lived companies)
    Received achievement reward at Osong Awards for Innovative Medicines (Hanguk KeungJe TV - Korea Food & Drug Administration)
    2010
    Received award from the Ministry of Strategy and Finance
    Completion of the research institute (Yongin, Gyeonggi-do)
    Gha Song Kwang-Yull Yoon, honorary chairman, passed away (Aug 26, 2010, at the age of 87)
    Chairman Doh-Joon Yoon gave a lecture at an international conference held to celebrate the 10th anniversary of Information Management School, Graduate School of Korea Hankuk University of Foreign Studies (topic: History moves hearts)
    Won EU Good Manufacturing Process (GMP) with Pantoprazole
    2009
    Won the Technology Export Prize at the KNDA
    Received 'Seoktop Industry Decoration' at the 36th Commerce & Industry Day
    Won 'Great Invention Prize' at the 44th Invention Day Ceremony
    Completion of Chungju cGMP plant
    Company was renamed as Dong Wha Pharm Co., Ltd.
    Chairman Yoon Doh Joon delivered the keynote speech at the international conference for an entrepreneurial spirit (Subject: Long-lived enterprise and entrepreneurial spirit)
    Won gold medal (Fucidin) and excellence award (Whal Myung Su (sparkling)) at annual Korea Advertising Awards
    Won silver medal, the Red Cross
    Published 'Secrete of Whal Myung Su's Centennial Growth'
    2008
    Dr. Doh-Joon Yoon named as new chairman
    Won Grand Prize of Korea’s First Brand (Whal Myung Su Q (sparkling), Fucidin, PANCOLD)
    Chang-Soo Cho inaugurated as 12th President
    Dong Wha and Teijin Pharma signed an agreement for novel osteoporosis treatment DW1350
    Gha Song Foundation was established (Chairman, Kwang-Yull Yoon and his wife Kim Sun Nyeo made personal donations)
    Completion of new company building, Gwangju branch
    Revealed a renewed CI
    Won business ethics award from Yonsei Business School
    Won HITEK Presidential Awards second consecutive year
    Won the Bronze Medal and selected as one of Top 10 Technologies in Korea
  • 2007
    Exclusive license agreement signed between Dong Wha and Pacific Beach BioSciences on DW224a
    Singed a license agreement of new drug DW1350 with P&G Pharmaceutical, the biggest in Korean pharmaceutical history
    Ground-breaking of New Choong-Joo cGMP standard Plant
    Won the 2007 New Drug Technology Development Awards
    Chairman Kwang-Yull Yoon won 'Korea Entrepreneurship Awards'
    Won Presidential Prize at HITEK 2007 (Health Industry Technology 2007)
    Received King Sejong Prize (the Korean Intellectual Property Office, the best patent title)
    2006
    Received the highest grade in GMP grade evaluation from KGMP
    Vice chairman Dr. Yoon Doh Joon's lecture on 'What makes longevity companies different' at a lecture hosted by Korean Management Association
    Fucidin won the grand prize as the country’s best brands chosen by women customer
    2005
    ISETAX PASTE, Treatment of Gum Diseases, launched on the market
    Dr. Doh-Joon Yoon appointed as new vice chairman
    'Dongwha HealthDaily' launched as Representative brand of Health Supplements
    'Whal Myung Su Q (sparkling)' selected as one of 2005 Top 100 brands by Brand stock
    2004
    Won an award from Minister of Health and Welfare (contribution to development of pharmaceutical industry and public health)
    Selected as No. 1 Korea Industry brand power (Korea Management Association, Marketing Committee: for two consecutive years)
    Completion of Anyang distribution center
    Won 'National decoration' (3rd times, on Food Safety Day)
    Whal Myung Su (sparkling) certified as Korea Top Brand by The Korea Economic Daily
    Formed a joint research contract to develop a stroke treatment
    Whal Myung Su (sparkling) won the 2004 SEOUL Commercial Awards
    DW1350 (treatment of osteoporosis) obtains a patent
    2003
    Kil-Joon Yoon became the 11th president.
    Whal Myung Su (sparkling) certified as Top Brand by Segye Times and ranked Brand Power by KMA(Korea Management Association)
    Received the 'Dongam Medical Research Award' (Yakup Newspaper)
    Selected as One of Best Science and Technology Companies (36th Science Day Anniversary)
    Won Order of Industrial Service Merit (Bronze Tower, Ministry of Industries and Energy)
    'VITACHUN plus' selected as one of the nation's 'Hit' products (9 major daily newspapers)
    Received Korean Business Leader Award (The Seoul Shinmun)
    2002
    Milican Inj. won Korea New Technology Award from Ministry of Commerce, Industry and Energy
    Milican Inj. won a KNDA(Korea New Drug Award) from Korea Drug Research Association
    Qualified for BGMP
    Received a certification as the top brand (Whal Myung Su Q (sparkling), from The Segye Times)
    Dong Wha Pharm was introduced by the book 'Ethical Management is Competitiveness' (as a company with patriotic philosophy and the country’s oldest bio company)
    Received a commendation of the Prime Minister in industrial cooperation category
    2001
    Qualified for KGSP
    KFDA approved sales of Milican Inj., the first radiopharmaceutical for the treatment of liver cancer in the world.
    Won Grand Prize at 10th Dasan Technology Award by Korea Economic Daily
    Received 'Gyeonggi Green Environment' Award (Gyeonggi-do)
    2000
    Received the 'Company for Economic Justice Awards' by the Economic Justice Institute and Hankyoreh Shinmun
    Obtained the European Directorate for the Quality of Medicines (EDQM) certificate
    Selected as one of Kyunghyang's best long-lived products (Whal Myung Su Q (sparkling))
    1999
    Won the 'Global Grand Prize of Consumer's Brand Association in 1999' with FUCIDIN (oint.) and Whal Myung Su Q (sparkling) (oral liquid digestive drug)
    1998
    DW-167, an innovative anti-skin cancer agent on a patch, formed an exclusive license agreement with the Korea Atomic Energy Research Institute
    Published 'Centenary History of DONG WHA PHARM. IND. CO.,LTD'
    1997
    Celebrated the 100th anniversary
    Local clinical trials of DW-116, a new fluoroquinolone, and DW-166HC, a treatment for liver cancer, started
    Won a prize as an exemplary enterprise taxpayer on the Taxpayer's Day (National Tax Service)
  • 1996
    Kyu-Oun Hwang sworn in as 10th president.
    Noted in Guinness Book of Korea Records as the first manufacturer and the first pharmaceutical company in Korea as well as a company which received the first registered trademark, BU-CHAE PYO, in Korea and has the oldest medicine, WHAL MYUNG SU.
    Signed a contract for joint development and exclusive right of DW166HC (Medicine for liver cancer) with Korea Atomic Energy Research Institute
    1995
    Awarded Citizens' Order (Peony Award) on the occasion of Health and Social Welfare Day
    Awarded Denmark's Prince Henrik's Medal of Honour and Diploma of Denmark Industry Association
    Received the Medical Research Award (Yakup Newspaper)
    Commemorative Stone for YUNTONG BU SEOUL erected in Head Office.
    Designated as 'Exemplary Business in Environmental Management' by the Ministry of Environment
    1994
    Won the 'IR52 Chang Young Shil Award' from the Minister of Science and Technology for successful development of Ambroxol HCL, an expectorant.
    Commercial film of WHAL WON won the 'Korea Advertising Award' (Division of drug.)
    FUCIDIN ointment and HOME-MAT mosquito repellent included in the Millennial Time Capsule to commemorate the 600th anniversary of Seoul City
    Selected as a prime enterprise (by Korean Management Association)
    1993
    Won Excellent Enterprise Awards from KMA
    LUBBOC, a bone graft, launched under the contract of exclusive sale with TRANSPHYTO, FRANCE
    Medical Business Department established.
    CALCIN chewable tab., a pediatric calcium supplement, launched under the contract of exclusive sale with SATO, JAPAN
    1992
    Expansion of food line, expanded into health food drink market.
    1991
    Qualified as KGMP company for the entire product range
    Robotization and high-speed automation of liquid preparation production line completed.
    1990
    Animal laboratory qualified for GLP
    EUROBIOL, a high-potency enzymatic digestive, launched under the license of JOUVEINAL, FRANCE
    1989
    MERALOP, a visual adaptation modifier, launched under the license of TRANSPHYTO, FRANCE
    1988
    Won the Iron Tower (Chultab) as an exemplary taxpayer
    LACTEOL, launched under the license of LACTEOL S.A., FRANCE
    Awarded for its support for the 24th Seoul Olympic Games
    1987
    Extension and opening of the computer room
    Donated money to help flood victims
    Chemical mass production of TERFENADINE, an antihistamine, started
    AFTACH BITABS, a stomatitis therapy, launched under the contract of exclusive sale with TEIJIN, JAPAN
    The company qualified for KGMP
    1986
    Central Research Laboratories exempted for military service as a special research facility
    Won the Minister of Trade and Industry Awards
    1985
    Received a presidential citation on Taxpayers' Day
    KGMP plant completed and lyophilizing facilities built
    CEFMETAZONE, a 2nd generation cephem antibiotic injection, launched under the license of SANKYO, JAPAN
    MENOCTYL, an irritable bowel syndrome therapy, launched under the license of MENARINI, ITALY
    1984
    SANDOZ KOREA LTD, a joint venture company with SANDOZ, established.
    GLIDE, an antiulcer agent, launched under the license of CRINOS, Italy
    STERIHYDE, a disinfectant of medical devices, launched under the contract of exclusive sale with MARUISHI, JAPAN
    Received a commendation of the Prime Minister (for contribution to development of export industry and new market)
    1983
    Won the Minister of Trade Prize for Exports
    1982
    Won the Minister of Health and Social Welfare Prize for Technical innovation and Exports
    HELMIN, a hepatoprotector, launched under the license of DEXO, FRANCE
    Sandoz local branch opened in Korea
    1981
    Production facilities of Semi-synthetic penicillin antibiotics expanded.
    1980
    Won the Minister of Trade and Industry Prize for Development of patented article and Exports
    FUCIDIN OINT, a topical antibiotic, launched under the license of LEO, DENMARK
    Constructed an employee welfare center
    1979
    The 2nd Chemical Synthesis Plant completed.
    Won the Minister of Labor Awards for improvement of welfare
    Won the Minister of Health and Social Welfare Awards for Exports
    'TENEBRA', an aminoglycoside antibiotic, launched.
    Won the 'Melode' lawsuit against Roche
    1978
    Monthly compensation system for entire employees started (for the first time in Korea)
    Manufacturing facilities for parenteral preparations completed.
    1977
    Gha Song Kwang-Yull Yoon took office as a chairman
    SILVADENE cream, a topical burns therapeutics, launched, under the license of MARION LAB.,U.S.A.
  • 1976
    First public stock offering made
    Implemented a stock-sharing plan for employees
    BURINEX, a diuretics, launched. (under the contract of exclusive sale with LEO, Denmark)
    Hosted ceremony for the statue of Bo-Dang Chang-Sik Yoon
    1975
    Organized a union
    1974
    Gha Song Kwang-Yull Yoon appointed as vice-chairman
    Held the first general meeting of stockholders
    Hong Kee Kim became 8th president.
    Won the Bronze Tower (DongTab), the order of industrial Merit
    Product Manager (PM) System was introduced.
    1973
    Kwang-Yull Yoon became 7th president.
    DONG WHA RARE DRUG CENTER, the only one in Korea, established
    Central Research Laboratories opened
    1972
    ANYANG Plant completed
    Chemical mass production of METOCLOPRAMIDE and TRIMETHOPRIM started
    Launched TAVEGYL, METHERGIN and OPTALIDON (Technical Assistance Agreement with SANDOZ, SWITZERLAND signed)
    1971
    Bought HYUN DAE GLASS IND.CO.,LTD
    Built 1st Chemical synthesis plant
    1970
    Established a branch office in Inchon
    Selected as an exemplary corporate taxpayer
    1969
    Established a branch office in Busan
    1968
    Launched ALPS-D, a tonic drink, ALPHA WHAL MYUNG SU, an oral liquid digestant and PANCOLD-A, an oral liquid cold remedy
    1967
    Received Bongwhang Award (with Whal Myung Su)
    1966
    Chairman Min-Gang buried at the Seoul National Cemetery
    1965
    Head Office Building and Soonwha Dong Plant were completed.
    1964
    Constructed the first factory facility
    Formed a technological alliance with Morimoto Corporation in Japan
    1963
    Wha-Yull Yoon sworn in as 6th president.
    Bo-Dang Chang-Sik Yoon passed away (March 13, 1963, at the age of 74)
    First chairman Min-Gang awarded a medal for hiss contributions to foundation of modern Korea, 'Dok-lip Jang'
    1962
    Change of the company's name to 'DONG WHA PHARM.IND.CO.,LTD.'
  • 1957
    Released 11 medicines including 'Cohunamin' syrup
    1949
    Gha Song Kwang-Yull Yoon joined Dong Wha Pharmacy Corporation
    1946
    Chairman Chang-Sik Yoon served as head of the Central Industrial Committee of the Korean National Association for Promotion of Independence
    1945
    Gha Song Gwang-Yull Yoon joined the independence army as Commander of company 5 in Ju Ho region
    1942
    Established branch plant (Andong, Manchuria)
    1939
    Established company policy and procedures
    1938
    Branch office in Manchuria was established.
    Appointed the first female pharmacist Jang Geum-san (as branch manager of Andong, Manchuria)
    1937
    Chang-Sik Yoon (Bo Dang) became 5th president.
    'Bu Chae Pyo Whal Myung Su' filed an application for trademark in Manchukuo (the first registration of trademark abroad)
    1931
    Company's name changed to 'DONG WHA YAK BANG CO.,LTD.'
    1927
    Bo-Dang Chang-Sik Yoon engaged in Sin-gan-hoe activities (resistance movement against Japan)
    1922
    Bo-Dang Chang-Sik Yoon engaged in Bolin-hoe activities (helping needy people)
    1919
    Registration of trademark 'Whal Myung Aek' (The country’s first anti-trademark piracy brand)
    Dong Wha Yak Bang acted as a base for Seoul Yeon-Tong bu
    1917
    Released cosmetics, 'I-Hwa bun', and 'Do-Hwa bun'
    1915
    Provided support for So-Ui School (Donate entire profits made from sales at Joseon Corporation Fair)
    Bo-Dang Chang-Sik Yoon , formed the Joseon association of economic operations (resistance movement against Japan), served as a general affair manager
    1912
    A full-page 'Happy New Year' advertisement (Maeilsinbo)
    Published an ad for cosmetics 'Dong Wha baekbun', 'Okyong-Su', and 'Wisaeng-Yu' in a newspaper
    1910
    Trademark 'Bu Chae Pyo' (Fan) registered
    Established and adopted the country’s first sales procedures and policy
    1909
    Filed a patent for 'Hwan-Yak' (295th of the Patent bureau of the Residency-General)
    Formed a Min-Gang, a Korea youth organization (resistance movement against Japan)
    1908
    Formed a Min-Gang, Korea youth organization (resistance movement against Japan)
    1907
    Established Min-Gang, So-Ui(昭義) school
    1906
    Established Joseon Pharmacy School (present School of Pharmacy, Seoul National University)
    1897
    'WHAL MYUNG SU' was developed by MIN, Byung Ho.
    'DONG WHA YAK BANG' was founded by MIN, Kang.